News for Bausch Health Companies Inc. (BHCN.MX)

Summary On July 24, 2025, Bausch Health Companies Inc (BHC), a global leader in the pharmaceutical industry, announced the appointment of Michael Goettler and S

LAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced th

Bausch Health Companies, under the ticker BHC, has announced the addition of Michael Goettler and Sandra Leung to their Board of Directors, effective from July

Bausch Health (BHC) expands its Board of Directors from ten to twelve members. Michael Goettler, former CEO of Viatris, and Sandra Leung, former Executi

PR NewswireOKLAHOMA CITY, July 22, 2025 OKLAHOMA CITY, July 22, 2025 /PRNewswire/ -- SandRidge Energy, Inc. (the "Company" or "SandRidge") (NYSE: SD) today

Brett Icahn joins SandRidge Energy's (SD) Board of Directors, effective August 1, 2025. This appointment increases the board size to six members. Bre

Bausch Health Companies Inc. (NYSE:BHC) is one of the 13 Best Healthcare Stocks to Buy Under $10. On July 9, Bausch Health Companies Inc. (NYSE:BHC), Canada, announced the availability of CABTREO gel 1.2% w/w, 0.15% w/w, and 3.1% w/w to beneficiaries of the public drug plans of Nova Scotia and Ontario. The gel, which treats acne vulgaris, […]

Summary Bausch Health Companies Inc (BHC), a global leader in the pharmaceutical industry, announced on July 10, 2025, the appointment of Steven Lee as the new

Bausch Health's acne treatment CABTREO is now available under Ontario and Nova Scotia public drug plans and two federal programs. CABTREO is the first tripl

Bausch Health (BHC) appoints Steven Lee as Chief Accounting Officer, effective July 14, 2025. Lee brings over two decades of financial leadership experi

Bausch Health (BHC) has announced that its CABTREO gel, used to treat acne vulgaris, is now accessible to those covered by Ontario and Nova Scotia's public drug

Bausch Health's CABTREO acne treatment is now covered by public drug plans in Ontario and Nova Scotia as well as federal programs. The topical gel combi

Bausch Health (BHC) and its gastroenterology arm, Salix Pharmaceuticals, launch "I Wish I Knew" campaign for Xifaxan® to educate about overt hepatic encep

U.S. stocks were higher, with the Dow Jones index gaining around 150 points on Wednesday. Shares of GMS Inc. GMS rose sharply during Monday's session after the...

I'll use my best judgment to complete the article based on the information gathered.

We recently published a list of LOOK: These 10 Stocks Just Stole The Show. In this article, we are going to take a look at where Bausch Health Companies Inc. (NYSE:BHC) stands against other best-performing stocks of Friday. Bausch Health extended its winning streak to a sixth consecutive day on Friday, ending 8.53 percent higher […]

You may be concerned about the recent declines in AI stocks such as NVDA.

Exploring the Latest 13F Filing and Investment Strategies John Paulson (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2025, pro

LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its